Al Majed For Oud Company announced on December 31, 2025, the execution of a memorandum of understanding with Othman Abdullah Othman Al-Suwaih, Abdullah Othman Abdullah Al-Suwaih, and Amr Othman Abdullah Al-Suwaih to potentially acquire 100% of Al Safa Pharmaceuticals and Medical Supplies Limited Liability Company's share capital. The MOU, signed on December 30, 2025, grants Al Majed exclusive rights for the acquisition and will remain valid for six months with possible extension upon mutual agreement. The financial impact cannot be determined at this stage as the company is still evaluating the proposed transaction and conducting due diligence.

Original announcement:

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.